(E)-5-(2-Carboxyvinyl)-2′-deoxyuridine CAS:74131-06-9

(E)-5-(2-Carboxyvinyl)-2′-deoxyuridine plays significant roles in nucleic acid research and antiviral drug development due to its distinctive properties. In nucleic acid research, it serves as a vital probe for studying DNA replication, repair mechanisms, and nucleic acid interactions. Its structural resemblance to thymidine allows for its incorporation into DNA strands, enabling researchers to label and track DNA synthesis and replication processes. Moreover, (E)-5-(2-Carboxyvinyl)-2′-deoxyuridine shows promise in antiviral drug development, particularly against herpesviruses. By inhibiting viral DNA synthesis, it interferes with viral replication and propagation, offering potential therapeutic benefits in the treatment of herpesvirus infections. Research efforts are underway to explore its efficacy and safety profiles for clinical applications in antiviral therapy. Furthermore, this compound finds utility in the development of diagnostic tools for viral infections. Its ability to selectively target viral DNA synthesis makes it a valuable component in nucleic acid-based detection assays, enabling the sensitive and specific detection of herpesviruses and related pathogens. Additionally, (E)-5-(2-Carboxyvinyl)-2′-deoxyuridine exhibits potential applications in cancer therapy. By targeting rapidly dividing cells, including cancer cells, it may exert cytotoxic effects and inhibit tumor growth. Research studies aim to elucidate its mechanisms of action and assess its therapeutic potential in various cancer types. The versatility of (E)-5-(2-Carboxyvinyl)-2′-deoxyuridine in nucleic acid research, antiviral drug development, viral diagnostics, and cancer therapy underscores its significance in biomedical research and pharmaceutical innovation. Continued exploration of its properties and applications holds promise for advancing our understanding of nucleic acid biology and improving treatment strategies for viral infections and cancer.